i.Mune™ NEO* is a molecular diagnostic test for early detection of inborn errors of immunity (IEI) in newborns.
i.Mune™ NEO* is suitable for epigenetic quantification of:
in dried blood spot (DBS) samples from newborns
23 out of 24 confirmed SCID or XLA cases were correctly identified using the epigenetic immune cell quantification method.
Using combined TREC/KREC Analysis, 22 out of 24 cases were correctly identified1)
Epigenetic immune cell quantification identifies false-positive SCID screening cases (Blom et al., 2021)
*i.Mune NEO is for research use, only and has not been registered as an IVD product and has not been approved or cleared by a regulatory authority.
**The above clinical applications are currently tested in several studies